Anyone surprised that Adam didn't bother showing up to ask questions? I guess he already knows more than the company and doesn't feel the need to disprove his theories/opinions on why to short IMGN and many other small companies.
I have never heard AF on any biotech quarterly cc. Impressive day for the stock. I am not under the belief that the quarterly accounting changed anything and I thought the Q&A was poor, but it's nice to have one up on a big down day. They sure hosed the premarket buyers, or at least gave them a scare. Curious to see what shorts do now. OT and IMO, it's a nice day to buy ARNA for those inclined.